Maven Securities LTD Edwards Lifesciences Corp Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $725,400 - $955,600	10,000 New	10,000 $955,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $273,051 - $335,455	-2,567 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $264,169 - $315,099	2,567 New	2,567 $291,000
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $1.34 Million - $1.54 Million	-17,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $1.22 Million - $1.55 Million	17,000 New	17,000 $1.55 Million

1,418

470M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.